Check out the SIU 2019 uMAG and see what activities and initiatives are taking place this year!
|
Help ensure SIU continues to offer the most relevant and effective educational content to urologists and residents from diverse resource and geographical settings. |
|
We invite you to complete this 10-minute needs assessment survey regarding SIU's educational offerings and your own learning needs. All responses will be kept confidential. |
|
|
SIU is excited to introduce the SIU Academy App! Now users can access educational content and activities anywhere, any time! Click here for more information on how to download for free.
Tremendous advancements have been made in diagnosis and treatment with the recent FDA approval of a targeted therapy for metastatic bladder cancer with FGFR3 or FGFR2 genetic alterations, two combination immunotherapy-targeted therapies as first-line treatment for advanced RCC, as well as advances in diagnostics and immunotherapy research for prostate cancer
Take advantage of this highly anticipated event and immerse yourself in the evolving landscape of urological cancer care.
For more information and to register, click here. Space is limited!
SIU’s upcoming B2B Uro-oncology meeting will bring together some of the lead investigators and surgeons in prostate, bladder and kidney cancer for one-and-a-half-days of cutting-edge scientific programming. Register now!
The SIU is pleased to announce its Board of Directors for 2019-2020.
Thank you to all those who presented their abstracts at the 39th SIU Congress in Athens last month. Congratulations to the winners of "best ePoster/video in session", selected by session moderators.
Every year, during the SIU Annual Congress, the Society recognizes outstanding contributions to the Society, and the field of urology through the presentation of various awards.
